GEVISKON (Pills)

Active material: Calcium carbonate, sodium alginate, Natriya carbonate
When ATH: A02AX
CCF: Antacids
ICD-10 codes (testimony): K30, R12
When CSF: 11.01.04
Manufacturer: RECKITT BENCKISER HEALTHCARE (UK) Limited (Great Britain)

Pharmaceutical form, composition and packaging

◊ Chewable Tablets (lemon) from almost white to cream-colored with small inclusions, round, flat, with beveled edges, with an image circle and sword on one side and the inscription “(G) 250” – another, with lemon odor.

Excipients: mannitol, macrogol, magnesium stearate, Aspartame, kopovydon, acesulfame potassium, lemon flavor.

8 PC. – blisters (1) – packs cardboard.
8 PC. – blisters (2) – packs cardboard.
8 PC. – blisters (3) – packs cardboard.
8 PC. – blisters (4) – packs cardboard.

◊ Chewable Tablets (mint) from almost white to cream-colored with small inclusions, round, flat, with beveled edges, with an image circle and sword on one side and the inscription “(G) 250” – another, with mint odor.

Excipients: mannitol, macrogol, magnesium stearate, Aspartame, kopovydon, acesulfame potassium, mint flavor.

8 PC. – blisters (1) – packs cardboard.
8 PC. – blisters (2) – packs cardboard.
8 PC. – blisters (3) – packs cardboard.
8 PC. – blisters (4) – packs cardboard.

Pharmacological action

Antacids. After intake of the drug quickly interacts with acidic contents of the stomach. When alginate gel, with an almost neutral pH value. The gel forms a protective barrier on the surface of stomach contents, preventing the occurrence of gastro-oesophageal reflux. In the case of regurgitation in the esophagus enters the gel, where it reduces irritation of mucous membrane.

Pharmacokinetics

The mechanism of action of the preparation Geviskon does not depend on the suction in the bloodstream.

Testimony

-symptomatic treatment of dyspepsia, associated with high acidity gastric juice and gastroezofagealnam reflux (heartburn, acid belching, feeling of heaviness in the stomach after eating, incl. Pregnancy).

Dosage regimen

The drug is prescribed inside (thoroughly chewing) adults and children over 12 years by 2-4 tab. After each meal and before bedtime.

Children under 12 years the dosage the doctor sets.

To elderly patients dose modification is not required.

Side effect

Maybe: allergic reactions.

Contraindications

- Hypersensitivity to the drug.

Pregnancy and lactation

Application of Geviskona in pregnancy and lactation (breast-feeding).

Open controlled trials involving 281 pregnant women and the experience gained in the use of have not demonstrated any significant adverse effects of the drug on Geviskon during pregnancy or on the health of the fetus and newborn.

Cautions

IN 4 Tablets contain 246 mg (10.6 mmol) sodium. This should be taken into account when the need to respect a diet with limited salt content (congestive heart failure, renal impairment).

IN 4 Tablets contain 320 mg (3.2 mmol) calcium carbonate. Caution must be exercised in the appointment Geviskona patients with giperkalcemiej, nefrocalzinozom and recurrent formation of kidney stones, containing calcium.

Because, that the product is aspartame, It should not be prescribed to patients with phenylketonuria.

There is the possibility of reducing the efficacy of Geviskon in patients with very low acidity gastric juice.

If after treatment during 7 days the symptoms of dyspepsia will not disappear, It is necessary to reassess the clinical condition.

Effects on ability to drive vehicles and management mechanisms

Effects on ability to drive vehicles and management mechanisms absent.

Overdose

Symptoms: abdominal distention.

Treatment: symptomatic therapy.

Drug Interactions

Patient interaction drug Geviskon not installed.

Conditions of supply of pharmacies

The drug is resolved to application as an agent Valium holidays.

Conditions and terms

The drug should be stored out of reach of children at temperature from 15 ° to 30 ° C. Shelf life – 2 year.